Floatz logo

Fast Laco-Stim Cdh17 Car-T

Multiple Cancer

Zhejiang UniversityCell therapyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Multiple Cancer cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Zhejiang University
Early Phase 1C
cdh17 car-t
Zhejiang University
Early Phase 1C
Fludarabine
Zhejiang University
Early Phase 1C

Same molecule, other indications

Fast Laco-Stim Cdh17 Car-T is also rated in:

gastric cancerDormant
C
Indicative ·
39 / 100
View asset →
pancreatic ductal adenocarcinomaDormant
C
Indicative ·
39 / 100
View asset →
biliary tract cancerDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →